Expression of mutant alpha-synuclein modulates microglial phenotype in vitro
about
Neuroinflammation in Parkinson's disease and its potential as therapeutic targetGlia and alpha-synuclein in neurodegeneration: A complex interactionNeuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunityProtective Microglia and Their Regulation in Parkinson's DiseaseBlockade of Kv1.3 channels ameliorates radiation-induced brain injury.Phagocytosis of microglia in the central nervous system diseasesA spirulina-enhanced diet provides neuroprotection in an α-synuclein model of Parkinson's disease.The role of Galectin-3 in α-synuclein-induced microglial activation.Studies of lipopolysaccharide effects on the induction of α-synuclein pathology by exogenous fibrils in transgenic mice.Alpha-Synuclein Proteins Promote Pro-Inflammatory Cascades in Microglia: Stronger Effects of the A53T MutantSuppression of MAPK attenuates neuronal cell death induced by activated glia-conditioned medium in alpha-synuclein overexpressing SH-SY5Y cells.Acetate reduces microglia inflammatory signaling in vitroApocynin prevents mitochondrial burdens, microglial activation, and pro-apoptosis induced by a toxic dose of methamphetamine in the striatum of mice via inhibition of p47phox activation by ERKEpigallocatechin-3-gallate: a useful, effective and safe clinical approach for targeted prevention and individualised treatment of neurological diseases?Distinct Lysosomal Network Protein Profiles in Parkinsonian Syndrome Cerebrospinal Fluid.Lipopolysaccharide-induced blood brain barrier permeability is enhanced by alpha-synuclein expressionCOX-2 in the neurodegenerative process of Parkinson's disease.The role of glia in α-synucleinopathies.What's to like about the prion-like hypothesis for the spreading of aggregated α-synuclein in Parkinson disease?Does restraining nitric oxide biosynthesis rescue from toxins-induced parkinsonism and sporadic Parkinson's disease?Studying neurodegenerative diseases in culture models.Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases.Targets and Mechanisms in Prevention of Parkinson's Disease through Immunomodulatory Treatments.Targeting Microglial Activation States as a Therapeutic Avenue in Parkinson's Disease.Toll-like receptor 4 is required for α-synuclein dependent activation of microglia and astroglia.Phagocytic Roles of Glial Cells in Healthy and Diseased Brains.Microglial Phagocytosis and Its Regulation: A Therapeutic Target in Parkinson's Disease?Microglia Response During Parkinson's Disease: Alpha-Synuclein Intervention
P2860
Q26783305-045D22A2-320B-43BA-993F-4C0B0BDE923EQ26851153-0646400B-977C-420B-AC48-9DFA289E03D7Q27027973-FDA27B70-1301-44C3-907E-6C949F26FA91Q28079731-CA1F1BBA-CDD5-43DB-BF15-BE6C517D8A47Q30708168-E000B19C-A2E6-48ED-9A86-BC5F9BAA519BQ33574527-16A85E5B-B861-4836-A79C-901403525FF1Q34428512-8134C222-7528-4E25-B657-CD4620CF7BF4Q34537231-E0128FC4-B486-4C35-9F82-A81912262819Q35903351-4A4B85D3-8B8A-44F1-9F6B-C7F8A682929DQ36131340-6E68B00A-E786-41B1-A821-AA19A2D5CAE2Q36215480-6F73D0D2-E19C-4111-8F9D-40FC0E008B21Q36319571-2D4F7BAC-9C4D-4FCB-95F5-CCD2E5D6C729Q36476821-675A101C-2F3F-48B2-AFC6-FA5B57C77BFAQ36648907-A71EE988-3AC5-4100-BD40-3920C1154476Q37054024-A8795935-8A79-471D-8BC9-A32F226224FAQ37237861-3ECDFB66-18E2-4527-A6AB-A7A70CB874DEQ38028894-45D33E1D-4EEE-43A7-A4F5-EAB39BB95A73Q38039880-937BAB59-1016-4076-A329-A9B036545D8AQ38077612-0C733298-A3E0-4C04-A0E9-B7B9CE38D7B5Q38125412-25150801-97AC-4BF2-A839-2AB91B9B29CFQ38165760-2BC36CB7-AF72-428E-BC0C-0839957F19DBQ38322767-3DB226FE-4D73-4FEF-94C9-5DB3D73EB6B9Q39148230-A531EAFD-91D9-43B7-A4DB-6F00EC4BF64AQ39392775-B6F40A50-BAB7-48A1-96EC-413B95C20A19Q41997706-84AE3E93-4D87-40B9-AA3E-30B39A9B4317Q47216715-6723C3F2-22D3-442F-8EEE-6773908B8254Q54942358-426C2336-AC4E-4A3B-AACD-689609CF7EA6Q58799080-F263AE1F-D2F2-4B6E-BC3F-486767663443
P2860
Expression of mutant alpha-synuclein modulates microglial phenotype in vitro
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Expression of mutant alpha-synuclein modulates microglial phenotype in vitro
@ast
Expression of mutant alpha-synuclein modulates microglial phenotype in vitro
@en
type
label
Expression of mutant alpha-synuclein modulates microglial phenotype in vitro
@ast
Expression of mutant alpha-synuclein modulates microglial phenotype in vitro
@en
prefLabel
Expression of mutant alpha-synuclein modulates microglial phenotype in vitro
@ast
Expression of mutant alpha-synuclein modulates microglial phenotype in vitro
@en
P2093
P2860
P356
P1476
Expression of mutant alpha-synuclein modulates microglial phenotype in vitro
@en
P2093
Colin K Combs
Eric J Murphy
Lalida Rojanathammanee
P2860
P2888
P356
10.1186/1742-2094-8-44
P577
2011-05-09T00:00:00Z
P5875
P6179
1039367492